BIMATOPROST/TIMOLOL SIFI 0.3mg / 5mg / ml ophthalmic drops solution medication leaflet

S01ED51 bimatoprost + timolol • Sensory organs | Antiglaucoma preparations and miotics | Beta blocking agents

The combination of bimatoprost and timolol is used to reduce elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension. Bimatoprost is a prostaglandin analog, and timolol is a beta-blocker; together, they work by increasing fluid outflow from the eye and reducing fluid production, thereby lowering pressure.

The medication is available as eye drops and is typically administered once daily in the evening. It is essential for patients to follow their doctor's instructions to prevent vision deterioration.

Common side effects include eye redness, burning sensation, itching, and dry eyes. In rare cases, systemic effects such as decreased heart rate or breathing difficulties may occur due to the presence of timolol.

This combination is not recommended for pregnant or breastfeeding women unless the benefits outweigh the risks. Patients should inform their doctor about any other conditions or medications being used to avoid drug interactions.

General data about BIMATOPROST/TIMOLOL SIFI 0.3mg / 5mg / ml

Substance: bimatoprost + timolol

Date of last drug list: 01-05-2021

Commercial code: W67498002

Concentration: 0.3mg / 5mg / ml

Pharmaceutical form: ophthalmic drops solution

Quantity: 3

Product type: generic

Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).

Marketing authorisation

Manufacturer: WARSZAWSKIE ZAKLADY FARMACEUTYCZNE POLFA S.A. - POLONIA

Holder: SIFI S.P.A. - ITALIA

Number: 13462/2020/02

Shelf life: 2 years-after packing for marketing;after opening a flac.-90 days

Pharmaceutical forms available for bimatoprost + timolol

Concentrations available for bimatoprost + timolol

0.3mg/5mg/ml, 300mcg/5mg/ml

Other substances similar to bimatoprost + timolol